Yuyu Pharma, Inc. (KOSE: A000220)
Health Care · Pharmaceuticals · KR
₩3,840.00
+1.59% today · -10.9% 1Y
Yuyu Pharma, Inc. (KOSE: A000220) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $44.98M.
Over the last twelve months the share price has lost 10.9%, trading between 3.32K and 5.10K.
Tweenvest scores Yuyu Pharma, Inc. across four factors: quality 83/100, value 85/100, dividend 57/100. Its strongest factor is value.
A000220 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.98M
- Revenue (TTM)
- $93.23M
- P/E
- 5.52
- EPS
- 695.09
- Dividend yield
- 2.99%
- Beta (5Y)
- 0.39
- 52-week high
- ₩5,100.00
- 52-week low
- ₩3,320.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.75M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioStem Technologies, Inc.NasdaqCM: BSEM | $45.90M | $2.47 | -9.52% |
| Pharmedic Pharmaceutical Medicinal Joint Stock CompanyHNX: PMC | $45.63M | ₫127,000.00 | +1.68% |
| Trident Lifeline LimitedBSE: 543616 | $45.62M | Rs370.00 | -1.69% |
| Vext Science, Inc.CNSX: VEXT | $45.14M | CA$0.26 | +15.56% |
| Oncoinvent ASAOB: ONCIN | $44.84M | Nkr70.00 | -15.46% |
| Advagene Biopharma Co., Ltd.TPEX: 6709 | $44.48M | NT$23.95 | -0.21% |
| Arovella Therapeutics LimitedASX: ALA | $43.87M | AU$0.05 | +10.64% |
| Grace Therapeutics, Inc.NasdaqCM: GRCE | $43.75M | $2.08 | +0.48% |
Figures last refreshed Oct 11, 2026.